These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
66 related items for PubMed ID: 11178535
1. Optimisation and establishing of serological methods for the potency testing of immunglobulins against Clostridium tetani-toxin. Ebert E, Abu Karim A, Kayser T, Wenig R, Weibetaer K, Wirz M, Pisani G, Schäffner G, Cubetaler K. ALTEX; 1998; 15(5):30-32. PubMed ID: 11178535 [Abstract] [Full Text] [Related]
2. Replacement of the Toxin Neutralisation Test in Mice by in vitro Serological Assay Systems for Potency Testing of Tetanus Toxoid Vaccines for Veterinary Use: Results of a European Collaborative Study. Hendriksen CF. ALTEX; 1994; 11(5):30-34. PubMed ID: 11178404 [Abstract] [Full Text] [Related]
4. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use. Hendriksen CF, Woltjes J, Akkermans AM, van der Gun JW, Marsman FR, Verschure MH, Veldman K. Biologicals; 1994 Sep; 22(3):257-68. PubMed ID: 7811460 [Abstract] [Full Text] [Related]
5. Serological methods for potency testing of tetanus toxoid vaccines for human use. Hendriksen C, Winsnes R. Dev Biol (Basel); 2002 Sep; 111():131-40. PubMed ID: 12678232 [Abstract] [Full Text] [Related]
6. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test. Rosskopf-Streicher U, Volkers P, Noeske K, Werner E. ALTEX; 2004 Sep; 21 Suppl 3():65-9. PubMed ID: 15057410 [Abstract] [Full Text] [Related]
9. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use. Lensing HH, Behr-Gross ME, Daas A, Spieser JM. Dev Biol (Basel); 2002 Sep; 111():69-76. PubMed ID: 12678226 [Abstract] [Full Text] [Related]
12. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines]. Luick K, Gottschaldt J, Schulze F, Werner E, Erler W, Borrmann E. Dtsch Tierarztl Wochenschr; 2002 Apr; 109(4):178-82. PubMed ID: 11998370 [Abstract] [Full Text] [Related]
15. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for serological potency testing of tetanus vaccines for human use: Clostridium tetani guinea pig antiserum (human). Hendriksen C, van der Gun J, Winsnes R, Urdal T, Rautmann G, Esposito-Farese ME. Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):7-11. PubMed ID: 11705101 [No Abstract] [Full Text] [Related]
16. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines. Lucken R, Daas A, Behr-Gross ME. Dev Biol (Basel); 2002 Aug; 111():171-80. PubMed ID: 12678238 [Abstract] [Full Text] [Related]
17. Determination of tetanus antitoxin levels in human immunoglobulins for intravenous use and in tetanus immunoglobulins by enzyme linked immunosorbent assay. Mainka C, Haase M. ALTEX; 1995 Aug; 12(1):24-30. PubMed ID: 11178413 [Abstract] [Full Text] [Related]